Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Covidien Gets 510(k) Clearance For IDrive Ultra Powered Stapling System

RELATED NEWS
Trade COV now with 

Covidien (COV: Quote), a global provider of healthcare products, announced it has obtained 510(k) clearance from the U.S. Food and Drug Administration for the iDrive Ultra powered stapling system. The iDrive Ultra system is the second offering in Covidien's line of powered stapling devices and the first that is compatible with the company's entire portfolio of Endo GIA reloads with Tri-Staple technology for use in laparoscopic and open surgical procedures.

The company said the new stapling system is the only fully powered, reusable, battery-operated endoscopic surgical stapler in the world. The system will be available In the U.S. beginning in the fourth quarter of 2012.

Click here to receive FREE breaking news email alerts for Covidien Plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Looking to increase pressure on Congress, the White House released a report on Tuesday warning of the economic costs of delaying action to address climate change. With the August recess looming, House Republican leaders are hopeful they can pass legislation to address the crisis along the U.S.-Mexico border before the end of the week. The House is expected to vote on a bill providing $659 million in funding for the border crisis, well below the $3.7 billion requested by the Obama administration. After moving mostly higher in early trading on Tuesday, stocks have given back ground over the course of the trading session. A negative reaction to news of new European sanctions against Russia contributed to the pullback by the markets.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.